Chr. Hansen, a developer and producer of natural ingredients, completed the acquisition of HSO Health Care, an Austria-based B2B company specializing in probiotics. Financial terms were not disclosed. “I am excited that we have reached an agreement with HSO Health Care, which has demonstrated very fast growth through a globally recognized portfolio that complements our own UREX™ products nicely. Women’s health is a high-growth segment where innovation is becoming increasingly important, and with the addition of the Astarte™ portfolio we will be able to deliver innovation to a much larger market more quickly,” Mauricio Graber, Chr. Hansen CEO.